BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 30852419)

  • 1. Glucagon-like peptide-1 attenuates endothelial barrier injury in diabetes via cAMP/PKA mediated down-regulation of MLC phosphorylation.
    Tang ST; Tang HQ; Su H; Wang Y; Zhou Q; Zhang Q; Wang Y; Zhu HQ
    Biomed Pharmacother; 2019 May; 113():108667. PubMed ID: 30852419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor κB signaling pathways.
    Tang ST; Zhang Q; Tang HQ; Wang CJ; Su H; Zhou Q; Wei W; Zhu HQ; Wang Y
    Endocrine; 2016 Jul; 53(1):107-16. PubMed ID: 26758998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of moesin in the effect of glucagon-like peptide-1 on advanced glycation end products-induced endothelial barrier dysfunction.
    Liu Y; Chen Z; Liu L; Tang H; Zhu H; Tang S
    Cell Signal; 2022 Feb; 90():110193. PubMed ID: 34785348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism.
    Wang D; Luo P; Wang Y; Li W; Wang C; Sun D; Zhang R; Su T; Ma X; Zeng C; Wang H; Ren J; Cao F
    Diabetes; 2013 May; 62(5):1697-708. PubMed ID: 23364453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin Attenuates Aortic Endothelial Permeability and Arteriosclerosis in Streptozotocin-Induced Diabetic Rats: Possible Role of MLCK- and MLCP-Dependent MLC Phosphorylation.
    Tang ST; Su H; Zhang Q; Tang HQ; Wang CJ; Zhou Q; Wei W; Zhu HQ; Wang Y
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):82-92. PubMed ID: 25944844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Glycation End Products Impair Ca2+ Mobilization and Sensitization in Colonic Smooth Muscle Cells via the CAMP/PKA Pathway.
    Yu T; Wang Y; Qian D; Sun X; Tang Y; Shen X; Lin L
    Cell Physiol Biochem; 2017; 43(4):1571-1587. PubMed ID: 29035879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 promotes endothelial barrier enhancement via PKA- and Epac1-dependent Rac1 activation.
    Li AQ; Zhao L; Zhou TF; Zhang MQ; Qin XM
    Am J Physiol Cell Physiol; 2015 Jan; 308(2):C164-75. PubMed ID: 25377089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17.
    Aslam M; Härtel FV; Arshad M; Gündüz D; Abdallah Y; Sauer H; Piper HM; Noll T
    Cardiovasc Res; 2010 Jul; 87(2):375-84. PubMed ID: 20202976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A.
    Oeseburg H; de Boer RA; Buikema H; van der Harst P; van Gilst WH; Silljé HH
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1407-14. PubMed ID: 20448207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner.
    Wei R; Ma S; Wang C; Ke J; Yang J; Li W; Liu Y; Hou W; Feng X; Wang G; Hong T
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E947-57. PubMed ID: 27072494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCβ activation in diabetes.
    Mima A; Hiraoka-Yamomoto J; Li Q; Kitada M; Li C; Geraldes P; Matsumoto M; Mizutani K; Park K; Cahill C; Nishikawa S; Rask-Madsen C; King GL
    Diabetes; 2012 Nov; 61(11):2967-79. PubMed ID: 22826029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite effect of cAMP signaling in endothelial barriers of different origin.
    Bindewald K; Gündüz D; Härtel F; Peters SC; Rodewald C; Nau S; Schäfer M; Neumann J; Piper HM; Noll T
    Am J Physiol Cell Physiol; 2004 Nov; 287(5):C1246-55. PubMed ID: 15475517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model.
    Gaspari T; Liu H; Welungoda I; Hu Y; Widdop RE; Knudsen LB; Simpson RW; Dear AE
    Diab Vasc Dis Res; 2011 Apr; 8(2):117-24. PubMed ID: 21562063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine-induced phosphorylation of the regulatory light chain of myosin II disrupts the barrier integrity of corneal endothelial cells.
    Srinivas SP; Satpathy M; Guo Y; Anandan V
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4011-8. PubMed ID: 16936117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A attenuates endothelial cell barrier dysfunction induced by microtubule disassembly.
    Birukova AA; Liu F; Garcia JG; Verin AD
    Am J Physiol Lung Cell Mol Physiol; 2004 Jul; 287(1):L86-93. PubMed ID: 15003930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation.
    Dozier KC; Cureton EL; Kwan RO; Curran B; Sadjadi J; Victorino GP
    Peptides; 2009 Sep; 30(9):1735-41. PubMed ID: 19560500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of glucagon-like peptide-1 on cardiac remodeling by inhibiting oxidative stress through mammalian target of rapamycin complex 1/p70 ribosomal protein S6 kinase pathway in diabetes mellitus.
    Wang D; Jiang L; Feng B; He N; Zhang Y; Ye H
    J Diabetes Investig; 2020 Jan; 11(1):39-51. PubMed ID: 31199578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium.
    Wallner M; Kolesnik E; Ablasser K; Khafaga M; Wakula P; Ljubojevic S; Thon-Gutschi EM; Sourij H; Kapl M; Edmunds NJ; Kuzmiski JB; Griffith DA; Knez I; Pieske B; von Lewinski D
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):365-75. PubMed ID: 26432951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells.
    Ding L; Zhang J
    Acta Pharmacol Sin; 2012 Jan; 33(1):75-81. PubMed ID: 22120969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.